In a follow-up study of previous research from John Hopkins University, scientists have concluded that the addiction-fighting properties of psilocybin keep ex-smokers away from cigarettes even 16 months after stopping treatment.
Psychiatry researchers recruited 15 lifetime smokers at an average age of 50 years old who smoked a pack of cigarettes per day. Over the 30+ years of smoking, all of them had already tried quitting one way or another at least six times. The researchers gave them controlled doses of psilocybin, starting small at 20 mg, and gave them one-on-one counseling about their addiction.
Six months later, 80 percent of them had quit smoking, or 12 of the initial 15, had quit. After 12 months, 10 remained abstinent, and after more than 16 months, nine still didn’t smoke—60 percent of the initial 15 participants. Comparatively, Psilocybin (a Schedule I Controlled Substance) almost doubles the success rate of FDA-approved, smoking-cessation drug Chantix (varenicline), which has a 36 percent success rate.
This research shows promise for the future of a mushroom drug that can help you quit smoking, but only when coupled with the proper therapy and counseling. Unfortunately, the FDA requires large-scale, double-blind placebo studies in order to approve a drug. Not only that, it would also help if scientists could learn how psilocybin works in this way.
Many smokers say that their psychological addition to the act of smoking something is much stronger than their physical addition to nicotine, a fact that complicates smoking cessation therapies significantly. Chantix works by getting in the way of nicotine receptors in the brain to essentially take the “high” out of smoking, but even after the nicotine craving is beaten, smokers still want to smoke something.
Psilocybin may be tackling the problem a little differently; scientists think that psilocybin coupled with therapy and deep contemplation can make you have revelations that can change your habits, urges and cravings.
“Quitting smoking isn’t a simple biological reaction to psilocybin, as with other medications that directly affect nicotine receptors,” said Matthew W. Johnson, lead author on both of the research papers. “When administered after careful preparation and in therapeutic context, psilocybin can lead to deep reflection about one’s life and spark motivation to change.”
A few years ago, the thought of a medical drug that is also a psychedelic seemed laughable. LSD has already made its away into migraine headache treatments, but in a modified form that does not produce a significant psychedelic experience. If scientists discover that the psychedelic effect of mushrooms is responsible for helping smokers quit, the day may soon come that a doctor prescribes tripping shrooms for quitting.
Comprehensive Marijuana Legalization Bill Introduced in Pennsylvania
Florida Man Calls Police to Report His Roommate For Stealing His Weed
NYPD Outreach Targets Neighborhoods Where Pot Laws Hit the Hardest
Eight Months After Ban, Food And Drink With CBD Is Still Being Sold In NYC
News5 days ago
Judge Says Police Seizure Of 900 Pounds Of Marijuana Was Illegal
News7 days ago
University In Houston Testing Psilocybin For Treatment-Resistant Depression
Business5 days ago
California Company Develops Metal-Free Vape Cartridge
News7 days ago
Over Two Dozen Medical Cannabis Growers in Pennsylvania Unionize
News4 days ago
Texas Suddenly Stops Issuing Permits For New Medical Marijuana Dispensaries
Grow5 days ago
Dear Danko: Expert Grow Advice
News6 days ago
Cannabis Advocacy Groups Bring 51-foot Inflated Joint To Congress
News6 days ago
California Medical Marijuana Bills Await Governor’s Signature